Daily Filing Digest: Tuesday, 20 Oct 2026

A light filing day for Vijayadashami. Police took Schaeffler India's CEO and Managing Director into custody in an investigation into a June accident at its Talegaon factory in which two workers died. Moody's affirmed Yes Bank's Ba1 deposit ratings and gave the first figure for the Supreme Court's AT-1 ruling: the bank's core capital ratio falls to 11.4% from 13.7% on a pro-forma basis. ICICI Life (formerly ICICI Prudential Life) received a rectified tax order taking the demand for assessment year 2023 to ₹591.42 crore, which it has appealed. India Ratings upgraded Karamtara Engineering to IND AA-. And Edelweiss's alternatives arm, EAAA India Alternatives, set its IPO for 26 to 28 October.

The ones to read first

• Schaeffler India: the filing states that CEO and Managing Director Harsha Gopal Kadam was taken into custody by the Talegaon MIDC police at about 6:40 p.m. on 19 October, under the Bharatiya Nyaya Sanhita.

  • The investigation concerns an accident at the Talegaon, Pune factory on 9 June 2026: two workers of a service provider died in "a sudden CO₂ gas discharge during scheduled cylinder replacement".
  • The filing says the scope of the investigation "has now been expanded to involve the Managing Director, on the basis that he is the 'occupier' of the factory premises under applicable law".
  • The company says senior management runs day-to-day operations, business continues "in the ordinary course", and it is evaluating the matter with legal advisers. It gives no estimate of financial impact.

• Yes Bank: Moody's affirmed its Ba1 deposit and issuer ratings (stable outlook) and its ba2 baseline credit assessment.

  • The release says "Management estimates the bank's CET1 ratio will decline to 11.4% from 13.7% on pro-forma basis as of September 2026" once the AT-1 bonds are reinstated, a fall of 2.3 percentage points (our arithmetic). The Tier 1 ratio stays unchanged because the bonds count as Tier 1 capital.
  • Moody's expects a one-time hit to profit and expects the bank to raise new equity. It would consider a downgrade if tangible common equity falls below 11% of risk-weighted assets "without clear visibility into a capital raising plan".
  • Separately, the bank corrected the cover page of its 17 October results letter: the joint auditors issued a qualified conclusion in their limited review, not an audit report with a modified opinion. Nothing else changes.
  • Full read: Yes Bank After AT-1: What Moody's Adds

• ICICI Life (formerly ICICI Prudential Life Insurance): the income-tax department issued a rectification order for assessment year 2023, adding ₹97.08 crore of tax and ₹133.11 crore of interest (rounded to crore).

  • The total demand is now ₹591.42 crore: tax ₹372.36 crore and interest ₹219.05 crore, no penalty.
  • The company says there is "No adverse material impact on the financial operations of the Company" and that it has appealed.

Q2 results

• Gallantt Ispat reported consolidated September-quarter revenue of ₹1,145.89 crore, up 13.1% from ₹1,012.78 crore, and profit of ₹60.51 crore, down 32% from ₹88.93 crore (growth rates and crore conversions are our arithmetic). Materials (raw materials, traded goods and the inventory change) took 79.0% of revenue against 74.5% a year earlier (our arithmetic), and pre-tax profit was ₹83.17 crore against ₹103.01 crore. The June quarter's profit was ₹123.67 crore.
• Varmora Granito's presentation gives September-quarter revenue of ₹399 crore (₹3,990 million), up 9%, EBITDA of ₹68.3 crore, up 19%, at a 16.9% margin, and profit of ₹44 crore, up 206% (crore conversions are our arithmetic). It started production at a new plant at Tezpur, Assam, stopped ceramic tile production at its Solaris unit (to be converted to glazed vitrified tiles) and sold its subsidiary Simola Tiles; the deck says the sale reduced revenue by about ₹52 crore (₹520 million).
• Shardul Securities, an investment company, reported a standalone September-quarter loss of ₹32.38 crore after a ₹39.81 crore fair-value loss on its investments; it had a profit of ₹131.65 crore in the June quarter (lakh figures converted to crore). Its buyback tender closes on 21 October (the scanned note gives the buyback's share count, price and total in figures that do not reconcile, so none is stated).

Deals and capital

• Edelweiss Financial Services: its subsidiary EAAA India Alternatives filed its red herring prospectus. The IPO comprises an offer for sale of up to ₹1,200 crore (₹12,000 million) by Edelweiss Securities & Investments, a wholly owned Edelweiss subsidiary. The price band is ₹1,585 to ₹1,665 a share (face value ₹5), in lots of nine shares.
• Indian Overseas Bank received SEBI's approval to issue up to 10 crore new shares directly to its employees through a share purchase scheme, as a way to meet the minimum public shareholding rule. SEBI's letter says the approval "shall not be treated as a precedent".
• OnEMI Technology Solutions (Kissht) received in-principle approval from NSE and BSE for its preferential issue of up to 2,64,93,882 shares at ₹314.11 to non-promoter investors, about ₹832.20 crore.
• Orchid Pharma's board passed an enabling resolution to raise up to ₹600 crore through a QIP, private placement, public or preferential issue or other routes, subject to shareholders.
• Vintage Coffee and Beverages' board approved raising up to ₹325 crore through equity or other securities, and doubled its borrowing, charge and lending limits to ₹1,000 crore each, subject to shareholders.
• Dr. Agarwal's Health Care: the merger of listed Dr. Agarwal's Eye Hospital into it takes effect on 1 November 2026 (appointed date 1 April 2026). Eye Hospital shareholders on the 18 November record date get 23 shares of ₹1 for every two shares of ₹10.
• Moneyview's board approved, for a postal ballot, new articles giving founders Puneet Agarwal and Sanjay Aggarwal the right to nominate one director each while they hold 5% together, and the Accel Group one director while it holds 10%. Shareholders are also asked to ratify the 2015 option plan and the company funding its employee trust's share purchases.
• Avalon Technologies incorporated Zollner Avalon as a wholly owned subsidiary; Zollner is to subscribe for 51%, making it the joint venture announced on 3 September.
• Grauer & Weil signed a memorandum of understanding with RENA Technologies of Germany for an equally managed joint venture serving solar manufacturing; RENA would license its technology for a fee or royalty. No size is given.
• Kapston Services' board approved splitting each ₹5 share into five ₹1 shares, subject to a postal ballot.
• Hexaware Technologies declared a second interim dividend of ₹9.50 a share.
• SIS completed its open-market buyback of 25,02,674 shares.

Orders and operations

• Venus Pipes & Tubes started part of its pipe-spooling capacity ahead of a December 2026 plan and has a letter of intent worth ₹185 crore from a data-centre customer, which it expects to start converting into firm orders "in the coming days". The rest of the capacity follows over the next few months.
• Quality Power Electrical Equipments began manufacturing at its new coil factory at Kupwad MIDC, Sangli, for high-voltage air-core reactors and coil products, ramping up as more lines are commissioned. No capacity or cost is given.
• Evervie Health (formerly PVP Ventures) signed a letter of intent to buy ten HARMONY linear accelerators from Elekta for its subsidiary Optimus Oncology, at an expected US$11–15 million, delivered in two batches by October 2028. The filing says the letter does not oblige Elekta to supply; a definitive agreement, approvals and financing are still needed.
• Sun Pharmaceutical: its skin-cancer drug UNLOXCYT was added to the NCCN guidelines as a Category 2A option for locally advanced cutaneous squamous cell carcinoma, adding to its 2025 listing for the metastatic form.

Ratings

• Karamtara Engineering: India Ratings upgraded its ₹2,432 crore of bank loans to IND AA-/Stable from IND A+, and the short-term rating to IND A1+. The agency cites FY26 revenue of ₹4,312 crore, up 37% (our arithmetic), an EBITDA margin of 11.6% (11.0% in FY25), EBITDA of ₹12,844 a tonne, and an order book of about ₹6,000 crore to be executed over 12 to 18 months. Solar structures were about 79% of FY26 revenue.
  • Full read: Karamtara's Upgrade: Margin per Tonne Held as Volume Rose
• Sudarshan Chemical: India Ratings revised the outlook to Positive from Stable, affirming IND AA on bank loans and fixed deposits and IND A1+ on commercial paper.
• Aseem Infrastructure Finance: India Ratings affirmed IND A1+ on ₹2,000 crore of commercial paper and withdrew its rating on ₹1,250 crore of debentures, which it had kept on Rating Watch with Negative Implications up to the withdrawal.
• UFLEX: Crisil reaffirmed AA- with a Negative outlook on ₹4,600 crore of bank loans.
• TVS Motor: CARE reaffirmed AAA/Stable, on enlarged bank lines, and withdrew A1+ on ₹1,900.35 crore of short-term instruments after full redemption.

Regulators and the fine print

• NTPC said a news article claiming 7.43% profit growth and a buyback date is "factually incorrect and misleading" and matches none of its disclosures; it is taking the matter up with the publisher.
• Rashi Peripherals: NSE rejected its request to waive fines for not meeting the board-composition rule in Regulation 17(1A) in the June and September 2024 quarters; the fine is ₹1,67,560 including GST.

Dates to note

• 21 October: Shardul Securities' buyback tender closes.
• 23 October: EAAA India Alternatives' anchor bidding; the IPO is open 26 to 28 October.
• 26 October: record date for Hexaware's ₹9.50 dividend, paid 7 November.
• 1 November: Dr. Agarwal's Eye Hospital merger takes effect; record date for the share swap 18 November.

What we're not reporting

The rest of the day was routine: newspaper copies of results (UltraTech, Hindustan Zinc, Sobha, HFCL, LTTS and others), call and board-meeting notices (Titan, Birlasoft, IndiaMART, Bata, Intellect and others), registrar certificates, trading-window closures and option allotments.

BSE documents not on disk, so not read (headlines only): Takyon Networks' work order from IIT Kanpur (no value in the headline); KS Smart Technologies' proposed foreign step-down subsidiary; Elitecon International's postal-ballot results (outcome not in the headline); Prime Industries' four filings on a change in management; Mehul Telecom's new franchise store; Ushakiran Finance's recall of a 2019 company-secretary appointment; Simplex Realty's independent director completing a term; and BSE copies of filings read on NSE (Venus Pipes, NTPC, Orchid Pharma, Moneyview, HMA Agro, Tatva Chintan, AksharChem, Shree Ram Twistex).

Educational research, not investment advice. Every item is drawn from the company's own exchange filing, read from the primary document; derived figures are our arithmetic, labelled as such. No buy/sell recommendations, no price targets, no share prices. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.